Screening proportions for some groups of women are even lower, including Asian women (75%%), and women lacking a usual source of care (65%%) or health insurance (64 %) (CDC 2012b) [ 5].
Characteristics included proportion of individuals in a fasting state when screened, proportion of individuals with known diabetes among those screened, proportion of positive screenees returning for confirmatory diagnosis, and proportion of confirmatory testing done at public vs. private providers.
In this paper we show predicted screening proportions for 12 of the possible 160 combinations of risk factors, which we selected to show a wide variety of the possible combinations.
Based on this baseline percentage, using an alpha value of 0.025 to adjust for the comparisons with two clinics, a sample of 500 individuals will result in power of 80% for a screening proportion in the smaller implementation clinic of 0.147 or higher and a sample of 1000 individuals will result in power of 80% or higher for a screening proportion of 0.132 in the larger clinic.
We assessed 3-year screening proportions by categories of BMI, age, sex, race/ethnicity, and baseline hypertension and (except for blood glucose screening) diabetes mellitus status.
Among women of childbearing age, 79.2% strongly agreed/agreed that prenatal screening should be routinely conducted, and 88.5% responded similarly for postnatal screening – proportions that were significantly higher than those observed in the total sample (data not in table).
In prevalence screening the proportion of screen detected cancers diagnosed at stage I (Dukes' A) was 46.5%, but this fell to 41% for first incidence screening and to 35% for second incidence screening.
Results In the screening ages, the cure proportion for women with screen detected invasive cancer was 92% (95% confidence interval 75%to98%8%) and for symptomatic women was 66% (62% to 70%), a statistically significant difference in cure of 26% (16% to 36%).
Additional secondary outcomes measured at 6 months will include the proportion of people still screening positive for depression as measured with the GDS-15, participant's use of services as determined using a Client Services Receipt Inventory CSRII) and an economic measure of 'capability and wellbeing' the ICECAP-O [ 20]‐[ 22].
Samples were screened for the proportion of missing genotypes, and animals with greater than 10% missing genotypes were removed.
